| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |